humanitarian
Archived signal
Human medicines European public assessment report (EPAR): Palbociclib Viatris, palbociclib, Date of authorisation: 19/06/2026, Revision: 1, Status: Authorised
Human medicines European public assessment report (EPAR): Phesgo, pertuzumab,trastuzumab, Date of authorisation: 21/12/2020, Revision: 8, Status: Authorised
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
12 reports · 2 sources
EMA What Is NewHuman medicines European public assessment report (EPAR): Palbociclib Viatris, palbociclib, Date of authorisation: 19/06/2026, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Palbociclib Viatris, palbociclib, Date of authorisation: 19/06/2026, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Tenkasi (previously Orbactiv), oritavancin, Date of authorisation: 19/03/2015, Revision: 18, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Tenkasi (previously Orbactiv), oritavancin, Date of authorisation: 19/03/2015, Revision: 18, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Pemazyre, pemigatinib, Date of authorisation: 26/03/2021, Revision: 8, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Pemazyre, pemigatinib, Date of authorisation: 26/03/2021, Revision: 8, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Vyepti, eptinezumab, Date of authorisation: 24/01/2022, Revision: 9, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Vyepti, eptinezumab, Date of authorisation: 24/01/2022, Revision: 9, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Winlevi, clascoterone, Date of authorisation: 17/10/2025, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Winlevi, clascoterone, Date of authorisation: 17/10/2025, Revision: 1, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 22, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Spinraza, nusinersen, Date of authorisation: 30/05/2017, Revision: 22, Status: Authorised4 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources
Source details updatedP2 · 99% quality · 2 sources